Abstract:Introduction: Orbital exenteration is a radical anatomically and psychologically disfiguring procedure. It is mostly performed for management of orbital cancers or cancers with orbital involvement. The lack of benefit in terms of overall survival and the development of new molecular therapies (targeted therapies, immunotherapy) in recent years leads us to question its use. The goal of our review is to answer to the following question: is orbital exenteration a viable procedure in 2019? Materials and methods: A literature review was performed using the PUBMED and MEDLINE databases. The following terms were used then crossed with each other: "orbital exenteration", "exenterated socket", "overall survival", "life expectancy", "orbital reconstruction", "socket reconstruction". Oncology articles from the past 15 years were included and separated into those in the oculoplastic literature and those in the ENT literature. Results: Nineteen articles were included in this review. Eyelid tumours represent the main etiology of orbital exenteration. Basal cell carcinoma is the most frequently incriminated tumor, while sebaceous carcinoma and conjunctival squamous cell carcinoma are the most frequently encountered in Asian series. Non-conservative orbital exenteration is the most prevalent surgery performed. Orbital reconstruction depends on the surgeon's speciality: healing by secondary intention and split thickness skin grafts are mostly performed by oculoplastic surgeons, whereas regional or free flaps are mostly performed by ENT surgeons. Cerebrospinal fluid leakage is the most common intraoperative complication, encountered in 0 to 13 % of cases. The most common postoperative complications are ethmoid fistula and infection of the operative site, encountered in 0 to 50 % and 0 to 43 % of cases respectively. Orbital exenteration allows surgical resection of R0 tumors in 42.5 % to 97 % of cases. Overall survival following orbital exenteration is 83 % (50.5-97) and 65 % (37-92) at 1 and 5 years respectively. Identified risk factors for poor overall survival are: age, tumor histology (worse prognosis with choroidal melanoma, better prognosis with basal cell carcinoma), non-R0 surgical resection, locally advanced tumors (size>20mm, BCVA<20/400 and the presence of metastases at diagnosis). Recent studies have demonstrated favorable outcomes when managing locally advanced basal cell carcinoma, lacrimal gland cancer and conjunctival melanoma with targeted therapies or immunotherapies without performing orbital exenteration. Conclusion: Orbital exenteration remains a major part of our therapeutic arsenal. Although orbital exenteration has failed to demonstrate any overall survival benefit, it allows satisfactory local control of the disease with an increasingly less invasive procedure. The development of targeted therapies and immunotherapies may change our therapeutic decisions in the future.

The Treatment of the Eyeball in Nasal Squamous Cell Carcinoma Invading the Orbit

Management Of Orbital Invasion In Sinonasal Squamous Cell Carcinoma: 15 Years' Experience

Endoscope-Assisted Supraorbital Keyhole Approach for the Resection of Benign Tumors of the Sellar Region

Management in Squamous Cell Carcinoma of Maxillary Sinus with Orbital Invasion

Microsurgical Resection of Sellar Tumors Via Lateral Supraorbital Approach:Clinical Analysis of 20 Cases

Recurrence in Eyelid Sebaceous Carcinoma: A Multicentric Study of 418 Patients.

From Seed to Spread: Lacrimal Sac Squamous Cell Carcinoma Blossoming Into Orbital Chaos

Orbital Exenterations: Experience of 189 Cases

Management of Orbital Contents in Advanced Malignant Maxillary Sinus Tumors with Orbital Invasion

Excision combined with ocular surface reconstruction followed by topical chemotherapy for ocular surface squamous neoplasia

Multimodal Treatment With Orbital Organ Preservation in Adult Patients With Locally Advanced Small-Round-Cell Malignancy of the Nasal Cavity and Paranasal Sinus

Analysis of radiotherapeutic strategy on adenoid cystic carcinoma in nasal cavity and sinuses with orbital invasion

Outcomes of orbital exenteration for craniofacial lesions

Treatment Outcomes of Low-grade Lymphoma of the Orbit

Comparison of Two Surgical Methods for the Treatment of Optic Pathway Gliomas in the Intraorbital Segment: an Analysis of Long-Term Clinical Follow-Up, Which Evaluates the Surgical Outcomes

[Does orbital exenteration still has a place in 2019?]

Clinical outcomes in perineural spread of cutaneous squamous cell carcinoma via the ophthalmic nerve

Modified transcranial orbitotomy for treating exophthalmic intraorbital tumor]

Orbital Exenteration for Conjunctival Melanoma: Comparison of Long-Term Outcome Between Individualised and Conventional Techniques

Factors for Postoperative Recurrence of Orbital Solitary Fibrous Tumor: an Analysis of Long‐term Clinical Follow‐up Results from a Chinese Tertiary Hospital

Management of orbital invasion in esthesioneuroblastoma: 14 years’ experience